Pharmafile Logo

Novltex

- PMLiVE

MHRA marks 100 years of patient safety through biological standards

The UK regulator highlights its century-long role in establishing safety and consistency benchmarks

- PMLiVE

Lilly and WHO Foundation partner to support global dementia action plan

The partnership will provide financial support and strengthen early detection and intervention efforts

- PMLiVE

New study highlights global overuse of antibiotics for diverticulitis

Researchers warn that excessive antibiotic use in diverticulitis increases risk of antimicrobial resistance and unnecessary hospital admissions

- PMLiVE

University of Liverpool identifies new class of antibiotic in fight against AMR

The new antibiotic class targets two of the WHO’s ‘priority pathogens’

- PMLiVE

UK government’s AMR study highlights importance of appropriate antibiotic use

The UKHSA found that some bacteria are already becoming resistant to ceftazidime/avibactam

- PMLiVE

AbbVie announces FDA approval of antibiotic combination for intra-abdominal infections

Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health

- PMLiVE

WHO urges US to ‘reconsider’ withdrawal from global health organisation

President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises

- PMLiVE

WHO launches $1.5bn emergency appeal to tackle ongoing health crises

The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people

- PMLiVE

WHO announces priority endemic pathogens for urgent vaccine development

The study identifies the 17 pathogens that regularly cause diseases in communities

- PMLiVE

UK study shows RSV vaccine could reduce antibiotic use and antimicrobial resistance

The new analysis found that RSV infections lead to 640,000 antibiotic prescriptions every year

- PMLiVE

Researchers identify free light chain targets to help treat rare form of amyloidosis

AL amyloidosis is currently the most common and severe form of the condition

- PMLiVE

WHO publishes guidance for HPV vaccine developers to help tackle cervical cancer

In more than nine out of ten cases, the HPV virus leads to cervical cancer, the fourth most common cancer in women globally

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links